… Conclusions: This study showed a high prevalence of IPIs in immunocompromised patients.
The results of this study suggest that periodic stool examinations for screening of IPIs should …

… gondii infection in immunocompromised patients in Iran were included in this review.
Eligibility of identified studies was assessed independently by two authors. Discrepancies were …

… Considering the scarcity of published reports on Pneumocystis jirovecii isolates from
patients in Mashhad, Iran, we aimed to evaluate pneumocystis colonization in individuals with …

… showed that among different immunocompromised patients, HIV-infected patients are more
susceptible PJP. Different studies have demonstrated that in HIV-infected patients, the risk of …

… of Chinese HIV + /AIDS patients [34]. In most of studies, the overall prevalence rate of intestinal
microsporidia among different groups of immunocompromised patients was similar to our …

… infection in immunocompromised patients to be 8.18% in Iran. In addition, …
immunocompromised patients with chronic diarrhea, 4.1% in patients without diarrhea, and 12.9% in …

… from Iranian patients, we investigated the genotypes of such isolates recovered from HIV-infected
patients, … However, specific haplotypes, such as Ne (the predominant haplotype from …

… , which emphasize the need for interventional measures at the community level to reduce
the risk factors of acquiring intestinal parasites in immunocompromised patients. Diarrhea is …

… in immunocompromised patients. … northeast of Iran as a pilgrimage region, and Kaposi's
sarcoma associated herpes virus (KSHV), as an oncogenic herpesvirus in immunocompromised …

… in the patients residing in different regions of Iran. Regarding … rate among immunocompromised
patients in developing … of this disease in the Iranian immunosuppressed patients [13-18]. …